ROTH.US Pharmaroth Labs Inc
- Market cap
- USD 1.49K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Dec 2017.
Is ROTH.US undervalued?
Graham numberThe Graham number of Pharmaroth Labs Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Pharmaroth Labs Inc fundamental analysis
No fundamental analysis for Pharmaroth Labs Inc yet.
Pharmaroth Labs Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Pharmaroth Labs Inc
PharmaRoth Labs, Inc. operates as a nutraceutical company worldwide. It focuses on producing, marketing, and distributing Sucanon, an herbal-based nutraceutical treatment for type-2 diabetes. The company was formerly known as Fero Industries Inc. and changed its name to PharmaRoth Labs, Inc. in March 2013. PharmaRoth Labs, Inc. was founded in 2000 and is based in Las Vegas, Nevada.
Full company profilePharmaroth Labs Inc financial statements
2017 annualized: Fiscal year 2017 is not finished. Income statement and cash flow are annualized from 2 quarters up to Dec 31, 2017, the balance sheet is the latest quarter. Figures change when the annual report is published.
Pharmaroth Labs Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2007 | 2008 | 2009 | 2010 | 2015 | 2016 | 2017 | 2017 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 87.0K | 263K | 182K | 20.7K |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 26.9K | 108K | 72.6K | 8.26K |
| Operating Income | -10.7K | -34.9K | -13.2K | -19.7K | -370K | -233K | -91.6K | -94.9K |
| Net Income | -10.7K | -34.9K | -13.2K | -270K | -370K | -233K | -91.5K | -95.2K |
| Balance Sheet | ||||||||
| Total Assets | 27.0K | 400.00 | - | - | 209K | 207K | 304K | 302K |
| Total Liabilities | 1.70K | 10.0K | 22.8K | 292K | 668K | 690K | 854K | 893K |
| Shareholders' Equity | 25.3K | -9.60K | - | - | -459K | -483K | -549K | -591K |
| Cash & Short-term Investments | 21.5K | 400.00 | - | - | 824.00 | 762.00 | 1.16K | 1.52K |
| Cash Flow | ||||||||
| Operating Cash Flow | -13.5K | -31.1K | -2.90K | -23.8K | -31.0K | -85.6K | -17.6K | -9.29K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Ratios | ||||||||
| ROE | -42.3% | - | - | - | - | - | - | - |
| ROA | -39.6% | -8,725.0% | - | - | -177.2% | -112.6% | -30.1% | -31.5% |
| Net Profit Margin | - | - | - | - | -425.4% | -88.4% | -50.4% | -460.8% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Pharmaroth Labs Inc dividends
Pharmaroth Labs Inc has not paid dividends in the last 7 fiscal years.
Last stock split: 5:1 on Jun 1, 2010.
Who owns Pharmaroth Labs Inc
Ownership data of Pharmaroth Labs Inc is not available yet.
Pharmaroth Labs Inc company profile
- Company name
- Pharmaroth Labs Inc
- Ticker
- ROTH.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Biotechnology
- Fiscal year end
- June
- Address
- 8250 West Charleston Boulevard, Las Vegas, NV, United States, 89117
- Phone
- 212-541-6222
- Website
- feroindustries.com
About Pharmaroth Labs Inc
PharmaRoth Labs, Inc. operates as a nutraceutical company worldwide. It focuses on producing, marketing, and distributing Sucanon, an herbal-based nutraceutical treatment for type-2 diabetes. The company was formerly known as Fero Industries Inc. and changed its name to PharmaRoth Labs, Inc. in March 2013. PharmaRoth Labs, Inc. was founded in 2000 and is based in Las Vegas, Nevada.
Pharmaroth Labs Inc management
2- Mr. Luis Manuel Ornelas LopezChairman, CEO, President & COO
- Mr. Barry W. HallInterim Chief Financial Officer · born 1948